340 related articles for article (PubMed ID: 8138935)
1. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
Rady JJ; Aksu F; Fujimoto JM
J Pharmacol Exp Ther; 1994 Mar; 268(3):1222-31. PubMed ID: 8138935
[TBL] [Abstract][Full Text] [Related]
2. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
5. Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Takemori AE; Portoghese PS; Fujimoto JM
Life Sci; 1994; 55(8):603-9. PubMed ID: 8046996
[TBL] [Abstract][Full Text] [Related]
6. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
[TBL] [Abstract][Full Text] [Related]
7. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Baemmert D; Takemori AE; Portoghese PS; Fujimoto JM
Pharmacol Biochem Behav; 1997 Feb; 56(2):243-9. PubMed ID: 9050081
[TBL] [Abstract][Full Text] [Related]
8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
10. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
11. Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors.
Rady JJ; Holmes BB; Portoghese PS; Fujimoto JM
Proc Soc Exp Biol Med; 2000 Jun; 224(2):93-101. PubMed ID: 10806416
[TBL] [Abstract][Full Text] [Related]
12. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice.
Rady JJ; Fujimoto JM
J Biomed Sci; 2000; 7(3):258-69. PubMed ID: 10810246
[TBL] [Abstract][Full Text] [Related]
13. Spinal GABA receptors mediate brain delta opioid analgesia in Swiss Webster mice.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1995 Aug; 51(4):655-9. PubMed ID: 7675839
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
Arts KS; Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1991 Mar; 256(3):890-6. PubMed ID: 2005587
[TBL] [Abstract][Full Text] [Related]
15. Heroin acts on delta opioid receptors in the brain of streptozocin-induced diabetic rats.
Holmes BB; Rady JJ; Fujimoto JM
Proc Soc Exp Biol Med; 1998 Sep; 218(4):334-40. PubMed ID: 9714077
[TBL] [Abstract][Full Text] [Related]
16. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
17. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
19. Antinociception produced by oral, subcutaneous or intrathecal administration of SC-39566, an opioid dipeptide arylalkylamide, in the rodent.
Hammond DL; Stapelfeld A; Drower EJ; Savage MA; Tam L; Mazur RH
J Pharmacol Exp Ther; 1994 Feb; 268(2):607-15. PubMed ID: 8113971
[TBL] [Abstract][Full Text] [Related]
20. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
